Merck KGaA ‘Consumer Centric’ Model Boosts Product Lines, Shapes R&D
This article was originally published in The Tan Sheet
Merck KGaA launches additional OTC products from brands associated with doctors or behind-the-counter sales or that currently are Rx to yield double-digit organic growth. The German firm is soliciting consumer feedback to shape its R&D and improve its understanding of factors driving the OTC market.
You may also be interested in...
OTC drug and supplement marketers could benefit from stronger outreach to independent pharmacists, via product education and patient sales collateral, pharmacists say in a Healthcare Distribution Management Association survey.
Revlon approved for $1.4bn debtor-in-possession financing from BrandCo Lenders, a group of operating subsidiaries formed in capital structure changes which owns much of Revlon’s intellectual property. Firm appoints interim CFO to set course for debt restructuring.
E.l.f. Beauty’s sales grew 26% to $122.6m in the fiscal 2023 first quarter, leading the Oakland, CA-based firm to increase full-year projections. According to company leadership, e.l.f. is capturing market share at a rapid clip while expanding distribution, notably in pharmacy retail.